Meeting
2011 ASCO Annual Meeting
Identification of previously unrecognized germline p53 mutations in Li-Fraumeni syndrome patients through retesting of archival DNA samples.
Authors
A. Novokmet
The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
A. Novokmet , B. Baskin , D. Malkin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Cancer Prevention/Epidemiology
Track
Cancer Prevention/Epidemiology
Sub Track
Cancer Genetics
Citation
J Clin Oncol 29: 2011 (suppl; abstr 1520)
Abstract #
1520
Poster Bd #
12
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Determining concordance of LFSPRO TP53 germline carrier risk predictions to standard genetic counseling practice.
First Author: Elissa B. Dodd-Eaton
Poster
2022 ASCO Annual Meeting
Fertility preferences, concerns, and preservation among young women with breast cancer who carry germline genetic pathogenic variants compared with non-carriers.
First Author: Rebecca M. Lewinsohn
Poster
2018 ASCO Annual Meeting
Mosaic TP53 pathogenic variants on multi-gene hereditary cancer panel testing: Clinical characteristics and follow-up testing.
First Author: Sarah A. Jackson
Poster
2017 ASCO Annual Meeting
Development and validation of a residual risk score to predict breast cancer risk in unaffected women negative for mutations on a multi-gene hereditary cancer panel.
First Author: Elisha Hughes